3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Conditions
Hemangioma
6
Hemangioma, Capillary
4
Multiple Myeloma
2
Fallopian Tube Neoplasms
2
Breast Neoplasms
2
Tuberous Sclerosis
1
Prostatic Neoplasms
1
Neuroblastoma
1
Melanoma
1
Hemangiosarcoma
1
Hemangioma, Cavernous, Central Nervous System
1
Carcinoma, Ovarian Epithelial
1
Carcinoma, Hepatocellular
1
Breast Neoplasms, Male
1
Interventions
Everolimus
12
Sirolimus
10
Cannabidiol
3
ganaxolone
2
Melatonin
2
Activator Appliances
2
radiprodil
1
Vigabatrin
1
Urination
1
Simvastatin
1
Propranolol
1
Doxycycline
1
Calcitriol
1
2-chloro-4-(1-(4-fluorophenyl)-2,5-dimethyl-1H-imidazol-4-ylethynyl)pyridine
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Tuberous Sclerosis
×
Propranolol
×
Clear all
NCT02104011
2026-05-19
STBETA
University Hospital, Bordeaux
Phase 2
Completed
2 enrolled